WOLF POPPER LLP FILES SECURITIES FRAUD CLASS ACTION AGAINST PAR PHARMACEUTICAL COMPANIES, INC.

Wolf Popper LLP has filed a securities fraud lawsuit in the United States District Court for the District of New Jersey on behalf of all persons who purchased the securities of Par Pharmaceutical Companies, Inc. ("Par" or the "Company") between April 29, 2004 and July 5, 2006, inclusive (the "Class Period"). Defendants include Par and certain of its senior officers and directors.
Medical News Today